Jonathan Marey
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 2
- Antifungal resistance and susceptibility 1
-
- Venous Thromboembolism Diagnosis and Management 3
- Co-authors
- Benjamin Planquette (2 shared papers)Olivier Sanchez (2 shared papers)Jean Pastré (2 shared papers)Guy Meyer (2 shared papers)David Jiménez (1 shared paper)Caroline Morbieu (2 shared papers)J. Texereau (2 shared papers)Anh Tuan Dinh‐Xuan (2 shared papers)
- Journals
- European Respiratory Journal (1 paper)EClinicalMedicine (1 paper)Respiratory Medicine (1 paper)The Lancet (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Jonathan Marey
16 papers receiving 1.3k citations
Jonathan Marey's Hit Papers
Peers
Comparison fields: 5 of 73
- Infectious Diseases 822
- Internal Medicine 94
- Immunology 196
- Neurology 113
- Critical Care and Intensive Care Medicine 12
Countries citing papers authored by Jonathan Marey
This map shows the geographic impact of Jonathan Marey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Marey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Marey more than expected).
Fields of papers citing papers by Jonathan Marey
This network shows the impact of papers produced by Jonathan Marey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Marey. The network helps show where Jonathan Marey may publish in the future.
Co-authors
The 24 scholars most cited alongside Jonathan Marey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 599 | |
| 2 | 2021 | 232 | |
| 3 | 2020 | 189 | |
| 4 | 2020 | 115 | |
| 5 | 2023 | 63 | |
| 6 | 2017 | 46 | |
| 7 | Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial Hit paper breakdown → | 2025 | 41 |
| 8 | 2021 | 36 | |
| 9 | 2018 | 19 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2024 | 4 | |
| 15 | 2020 | 2 | |
| 16 | 2024 | 2 |
About Jonathan Marey
Jonathan Marey is a scholar working on Infectious Diseases, Internal Medicine, Neurology, Immunology and Sensory Systems, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Genetic Associations and Epidemiology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Long-Term Effects of COVID-19 (2 papers), interferon and immune responses (2 papers), Antifungal resistance and susceptibility (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (822 citations), Internal Medicine (94 citations), Immunology (196 citations), Neurology (113 citations) and Critical Care and Intensive Care Medicine (12 citations). Jonathan Marey has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Benjamin Planquette, Olivier Sanchez, Jean Pastré, Guy Meyer, David Jiménez, Caroline Morbieu, J. Texereau, Anh Tuan Dinh‐Xuan, Nicolás Roche and Luc Mouthon. Their work appears in journals such as European Respiratory Journal, EClinicalMedicine, Respiratory Medicine, The Lancet and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.